These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34129198)

  • 1. The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer's disease, type 2 diabetes, and type 2 diabetes-related Alzheimer's disease.
    He L; Sun Y
    Metab Brain Dis; 2021 Oct; 36(7):1469-1479. PubMed ID: 34129198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer's disease in rats by targeting Keap1/Nrf2 and MAPK-38p/ERK signaling pathways.
    Saad El-Din S; Rashed L; Medhat E; Emad Aboulhoda B; Desoky Badawy A; Mohammed ShamsEldeen A; Abdelgwad M
    Steroids; 2020 Apr; 156():108586. PubMed ID: 31982424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review.
    Fakhri S; Pesce M; Patruno A; Moradi SZ; Iranpanah A; Farzaei MH; Sobarzo-Sánchez E
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33114450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ellagic acid ameliorates oxidative stress and insulin resistance in high glucose-treated HepG2 cells via miR-223/keap1-Nrf2 pathway.
    Ding X; Jian T; Wu Y; Zuo Y; Li J; Lv H; Ma L; Ren B; Zhao L; Li W; Chen J
    Biomed Pharmacother; 2019 Feb; 110():85-94. PubMed ID: 30466006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease.
    Sun Y; Huang J; Chen Y; Shang H; Zhang W; Yu J; He L; Xing C; Zhuang C
    Bioorg Chem; 2020 Oct; 103():104172. PubMed ID: 32890991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
    Sharma V; Kaur A; Singh TG
    Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
    Nezu M; Suzuki N; Yamamoto M
    Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-592 blockade inhibits oxidative stress injury in Alzheimer's disease astrocytes via the KIAA0319-mediated Keap1/Nrf2/ARE signaling pathway.
    Wu GD; Li ZH; Li X; Zheng T; Zhang DK
    Exp Neurol; 2020 Feb; 324():113128. PubMed ID: 31759899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease.
    Sun Y; Xu L; Zheng D; Wang J; Liu G; Mo Z; Liu C; Zhang W; Yu J; Xing C; He L; Zhuang C
    Redox Biol; 2023 Aug; 64():102793. PubMed ID: 37385075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenepezil, a Selenium-Containing Compound, Exerts Neuroprotective Effect via Modulation of the Keap1-Nrf2-ARE Pathway and Attenuates Aβ-Induced Cognitive Impairment in Vivo.
    Yan J; Pang Y; Zhuang J; Lin H; Zhang Q; Han L; Ke P; Zhuang J; Huang X
    ACS Chem Neurosci; 2019 Jun; 10(6):2903-2914. PubMed ID: 31035749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
    Fão L; Mota SI; Rego AC
    Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engeletin Attenuates Aβ1-42-Induced Oxidative Stress and Neuroinflammation by Keap1/Nrf2 Pathway.
    Huang Z; Ji H; Shi J; Zhu X; Zhi Z
    Inflammation; 2020 Oct; 43(5):1759-1771. PubMed ID: 32445069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
    Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
    Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy.
    Zhang W; Feng C; Jiang H
    Ageing Res Rev; 2021 Jan; 65():101207. PubMed ID: 33144123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors.
    Mou Y; Wen S; Li YX; Gao XX; Zhang X; Jiang ZY
    Eur J Med Chem; 2020 Sep; 202():112532. PubMed ID: 32668381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances of Natural Polyphenols Activators for Keap1-Nrf2 Signaling Pathway.
    Zhou Y; Jiang Z; Lu H; Xu Z; Tong R; Shi J; Jia G
    Chem Biodivers; 2019 Nov; 16(11):e1900400. PubMed ID: 31482617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus.
    David JA; Rifkin WJ; Rabbani PS; Ceradini DJ
    J Diabetes Res; 2017; 2017():4826724. PubMed ID: 28913364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Compound K Regulates Amyloid β via the Nrf2/Keap1 Signaling Pathway in Mice with Scopolamine Hydrobromide-Induced Memory Impairments.
    Yang Q; Lin J; Zhang H; Liu Y; Kan M; Xiu Z; Chen X; Lan X; Li X; Shi X; Li N; Qu X
    J Mol Neurosci; 2019 Jan; 67(1):62-71. PubMed ID: 30535776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases.
    Pallesen JS; Tran KT; Bach A
    J Med Chem; 2018 Sep; 61(18):8088-8103. PubMed ID: 29750408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy.
    Zhong Q; Mishra M; Kowluru RA
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3941-8. PubMed ID: 23633659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.